Scarica l'app Stockscreener
1.26
3.28%
0.04
Dopo l'orario di chiusura:
1.26
Panoramica
Notizia
Cronologia dei prezzi
Financials
Perché BBLG Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$1.22
Aprire:
$1.285
Volume 24 ore:
13,579
Relative Volume:
0.96
Capitalizzazione di mercato:
$2.26M
Reddito:
-
Utile/perdita netta:
$-2.86M
Rapporto P/E:
-0.5026
EPS:
-2.5071
Flusso di cassa netto:
$-2.57M
1 W Prestazione:
+0.00%
1M Prestazione:
-7.35%
6M Prestazione:
-11.27%
1 anno Prestazione:
-74.39%
Intervallo 1D:
$1.23
$1.30
Intervallo di 1 settimana:
$1.22
$1.30
Portata 52W:
$1.05
$6.75
Bone Biologics Corp Stock (BBLG) Company Profile
Nome
Bone Biologics Corp
Settore
Industria
Telefono
(781) 552-4452
Indirizzo
2 BURLINGTON WOODS DRIVE,, BURLINGTON
Compare BBLG vs VRTX, REGN, ARGX, ALNY, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BBLG
Bone Biologics Corp
|
1.26 | 2.19M | 0 | -2.86M | -2.57M | -2.5071 |
VRTX
Vertex Pharmaceuticals Inc
|
435.93 | 110.28B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
634.62 | 66.98B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
808.43 | 50.15B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
295.50 | 39.71B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
154.89 | 32.22B | 742.00K | -1.37B | -1.07B | -7.0731 |
Bone Biologics Corp Borsa (BBLG) Ultime notizie
BBLG Q1 2026 Earnings: Narrower-than-Expected Loss as Company Advances Bone Graft PlatformROIC Trend Report - Newser
BBLG Q1 2026 Earnings: Narrowed Loss Beats Estimates as Bone Biologics Advances PipelineOperating Income Trends - Newser
BBLG Q1 2026 Earnings: EPS Surprises to the Upside Despite No Revenue; Stock DeclinesAI Trading Community - Newser
Bone Biologics Corp (BBLG) Q1 2026 Earnings: Narrower Loss Beats Estimates, Shares DipSocial Signal Watchlist - Newser
BBLG Q1 2026 Earnings: Narrower-than-Expected Loss as Bone Biologics Advances DevelopmentFree Stock Community - Newser
Bone Biologics extends rhNELL-1 protein shelf life to 29 months - Investing.com
Spine fusion protein from Bone Biologics now lasts 29 months - Stock Titan
VBIO Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
VBIO PE Ratio & Valuation, Is VBIO Overvalued - Intellectia AI
Bone Biologics (BBLG) flags going concern, cash runway into Q4 2026 - Stock Titan
TradingKey - TradingKey
Bone Biologics Corp expected to post a loss of 54 cents a shareEarnings Preview - TradingView
How Bone Bio (BBLG) translates market opportunities into growth (-3.01%) 2026-05-08Undervalued Stocks - newser.com
What Bone Bio (BBLG) is doing that smarter investors notice (Smart Money Exits) 2026-05-07Stock Community Signals - Newser
What Bone Bio BBLG is doing that smarter investors notice Smart Money Exits 20260507Profit Announcement - Newser
Why Bone Bio (BBLGW) is trading below its true worth (Investor Concern) 2026-05-06Stock News - newser.com
Leading Companies Fueling Growth and Innovation in the Spine Biologics Market - openPR.com
BBLGW (Bone Bio) quarterly earnings release excludes core financial metrics, investors seek additional operational disclosures.Earnings Revision Downgrade - Newser
Bone Bio (BBLG) Stock: Volatility Overview (-1.78%) 2026-04-23Crowd Sentiment Stocks - Newser
BBLGW (Bone Bio) quarterly earnings carry no finalized public metrics as the firm wraps up internal financial reviews.Community Sell Signals - Newser
BBLGW (Bone Bio) quarterly earnings data unavailable, stakeholders await updates on core orthobiologics growth plans.Community Chart Signals - Cổng thông tin điện tử Tỉnh Sơn La
Trends in Growth, Segment Analysis, and Competitive Strategies Influencing the Orthobiologics Market - openPR.com
Is First Mid (FMBH) stock still a good play today (Flirts with Breakout) 2026-04-20Social Investment Platform - Cổng thông tin điện tử tỉnh Lào Cai
Aug Weekly: What is Bone Biologics Corporation Equity Warrants revenue forecastExit Point & Fast Moving Market Watchlists - baoquankhu1.vn
Stock List: Research Stocks from Around the World - GuruFocus
Entry Recap: What is the Moat Score of Bone Biologics CorporationQuarterly Performance Summary & Consistent Return Strategy Ideas - baoquankhu1.vn
Biocon Announces U.S. Commercial Launch of Bosaya™ and Aukelso™, Denosumab Biosimilars - PharmiWeb.com
Is Bel Fuse (BELFB) Stock at a Peak | Price at $204.62, Down 0.01%Community Driven Stock Picks - Cổng thông tin điện tử tỉnh Lào Cai
BBLGW Stock Analysis: Bone Biologics Corp Warrants Flat at 21 Amid Calm Biotech Trading - Newser
Market Structure, Emerging Trends, and Key Player Analysis in the Orthobiologics Devices and Equipment Sector - openPR.com
Earnings Update: Whats the profit margin of Aptiv PLC2026 Rallies & Capital Protection Trading Alerts - baoquankhu1.vn
TPB Stock Analysis: Turning Point Brands Inc drops 14.45% to 74.25 in selloff - Cổng thông tin điện tử tỉnh Lào Cai
Exit Recap: Is Bone Biologics Corporation a strong candidate for buy and holdEarnings Risk Summary & Low Risk Entry Point Guides - baoquankhu1.vn
Global Drivers Analysis: Factors Behind the Rapid Evolution of the Demineralized Bone Matrix Market - openPR.com
What technical signals show for Corporacion (VTMX) Stock | Price at $35.54, Up 0.11%ATR Levels - Cổng thông tin điện tử tỉnh Lào Cai
Aug PostEarnings: Is INNOVATE Corp a top pick in the sector2026 Valuation Update & Weekly High Conviction Ideas - baoquankhu1.vn
Competitive Analysis: Leading Companies and New Entrants in the Bone Graft Fixation System Market - openPR.com
Gains Report: What is the implied volatility of Bone Biologics Corporation Equity Warrant2026 Selloffs & Capital Protection Trade Alerts - baoquankhu1.vn
Aug Sentiment: Is Bone Biologics Corporation stock a good pick for beginners2026 Analyst Calls & Weekly Top Performers Watchlists - baoquankhu1.vn
Downgrade Watch: Is BCPC likely to announce a buyback2026 Key Highlights & Daily Profit Maximizing Tips - baoquankhu1.vn
If You Invested $1,000 in Bone Biologics Corp (BBLG) - Stock Titan
BBLG Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Market Leaders: Can Bone Biologics Corporation Equity Warrant sustain its profitability2026 Snapshot & Weekly Stock Performance Updates - baoquankhu1.vn
Bone Biologics Corporation Announces $1 Million At-the-Market Offering of Common Stock Through H.C. Wainwright & Co - Minichart
Bone Biologics launches $1.06 million at-the-market offering on Nasdaq - Investing.com
Bone Biologics launches $1.064M at-the-market equity program via H.C. Wainwright - TradingView
Bone Biologics (NASDAQ: BBLG) adds $1.064M at-the-market stock capacity - Stock Titan
Bone Biologics (NASDAQ: BBLG) launches $1.06M ATM sale with Wainwright - Stock Titan
BBLG PE Ratio & Valuation, Is BBLG Overvalued - Intellectia AI
Aug Movers: What is Bone Biologics Corporation Equity Warrant s revenue forecastGlobal Markets & Entry Point Strategy Guides - baoquankhu1.vn
Trading Action: Does NVFY stock benefit from AI growthPortfolio Value Summary & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn
Bone Biologics Corp Azioni (BBLG) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.98%
0.12%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):